Jolt Health Inc. (CNSX: JOLT.X)
Financials · Capital Markets · CA
CA$0.04
-22.22% today · -61.1% 1Y
Jolt Health Inc. (CNSX: JOLT.X) operates in the Capital Markets industry within the Financials sector. The company is valued at $629.64K.
Over the last twelve months the share price has lost 61.1%, trading between 0.03 and 0.14.
Tweenvest scores Jolt Health Inc. across four factors: quality 6/100. Its strongest factor is quality.
JOLT.X price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $629.64K
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -0.04
- Dividend yield
- —
- Beta (5Y)
- 1.44
- 52-week high
- CA$0.14
- 52-week low
- CA$0.03
- Avg volume (3M)
- —
- Shares outstanding
- 25.08M
- Employees
- —
- Next earnings
- —
About Jolt Health Inc.
Love Pharma Inc. focuses on mental health and sexual wellness by licensing and distributing psychedelic and hempinfused products in North America, the United Kingdom, and Europe. It offers BLOOM, a female arousal gel; and AURALIEF, a cannabis-infused sublingual strip. The company was founded in 2020 and is headquartered in Vancouver, Canada.
- ISIN
- CA4798612053
- Listed since
- Mar 18, 2010
- Exchange
- Canadian National Stock Exchange
- Currency
- CAD
Other Capital Markets companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Vanguard Index Funds - Vanguard Morningstar Total Stock Market ETFARCA: VTI | $2.32T | $377.07 | -0.31% |
| Vanguard Index Funds - Vanguard S&P 500 ETFARCA: VOO | $1.66T | $701.83 | -0.27% |
| iShares Trust - iShares Core S&P 500 ETFARCA: IVV | $889.41B | $767.13 | -0.28% |
| State Street SPDR S&P 500 ETF TrustARCA: SPY | $817.93B | $763.47 | -0.29% |
| Invesco QQQ Trust, Series 1NasdaqGM: QQQ | $480.69B | $706.32 | -1.00% |
| Vanguard Index Funds - Vanguard Morningstar Growth ETFARCA: VUG | $377.66B | $86.93 | -0.65% |
| Morgan StanleyNYSE: MS | $336.23B | $215.29 | +0.57% |
| The Goldman Sachs Group, Inc.NYSE: GS | $313.75B | $1,049.00 | +1.23% |
Figures last refreshed Aug 18, 2026.